Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Management
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week

Latest news

Group By Ticker
Sort By
Newest | Oldest
Read More
2 minute read
  • Cryptocurrency
  • Events
  • Exclusives
  • Markets
  • News

EXCLUSIVE: Why The Largest Custodian Bank In The World Sees Opportunity In Tokenization, Not Cryptocurrencies

By Adam Eckert
Today, 5:02 PM
State Street (NYSE: STT) has ramped up its focus on digital assets and tokenization as it sees significant opportunity in the space.

BTC

Read More
4 minute read
  • Intraday Update
  • Markets
  • Movers
  • News
  • Penny Stocks
  • Small Cap
  • Trading Ideas

Why Prometheus Biosciences Shares Are Trading Higher By Over 184%? Here Are 55 Stocks Moving In Wednesday’s Mid-Day Session

By Lisa Levin
Today, 5:02 PM
Gainers Prometheus Biosciences, Inc. (NASDAQ: RXDX) shares jumped 184.2% to $102.49 after the company announced results for PRA023 in both ARTEMIS-UC Phase 2 and APOLLO-CD Phase 2a studies. ARTEMIS-UC met the primary endpoint.

ALVO

Read More
1 minute read
  • Analyst Ratings

Expert Ratings for State Street

By Benzinga Insights
Today, 5:02 PM
State Street (NYSE:STT) has observed the following analyst ratings within the last quarter: Bullish Somewhat Bullish Indifferent Somewhat…

STT

Read More
2 minute read
  • Analyst Ratings

Analyst Ratings for State Street

By Benzinga Insights
Today, 5:02 PM
Over the past 3 months, 7 analysts have published their opinion on State Street (NYSE:STT) stock. These analysts…

STT

Read More
2 minute read
  • Analyst Ratings

7 Analysts Have This to Say About State Street

By Benzinga Insights
Today, 5:02 PM
Within the last quarter, State Street (NYSE:STT) has observed the following analyst ratings: Bullish Somewhat Bullish Indifferent Somewhat…

STT

Read More
1 minute read
  • Analyst Ratings
  • News
  • Price Target

Citigroup Maintains Neutral on State Street, Raises Price Target to $85

By Benzinga Newsdesk
Today, 5:02 PM
Citigroup analyst Keith Horowitz maintains State Street (NYSE:STT) with a Neutral and raises the price target from $81 to $85.

STT

Read More
1 minute read
  • Analyst Ratings
  • News
  • Price Target

Deutsche Bank Maintains Hold on State Street, Raises Price Target to $77

By Benzinga Newsdesk
Today, 5:02 PM
Deutsche Bank analyst Brian Bedell maintains State Street (NYSE:STT) with a Hold and raises the price target from $66 to $77.

STT

Read More
3 minute read
  • After-Hours Center
  • Cannabis
  • General
  • Markets
  • News
  • Politics
  • Small Cap

A Sinister Reason May Be Behind Governors’ Opposition To Cannabis Legalization

By Maureen Meehan
Today, 5:02 PM
As one Republican governor after another rejects President Biden’s suggestion to pardon simple cannabis possession convictions, one wonders what they're thinking.

ATAI

Read More
1 minute read
  • Markets
  • Media
  • News
  • Small Cap
  • Trading Ideas

Jim Cramer Says This Stock ‘Down Here At This Level Is A Terrific Buy’

By Priya Nigam
Today, 5:02 PM
On CNBC’s "Mad Money Lightning Round," Jim Cramer said he is against Novavax (NASDAQ: NVAX).

AMZN

Read More
3 minute read
  • Earnings

Earnings Scheduled For October 18, 2022

By Benzinga Insights
Today, 5:02 PM
Companies Reporting Before The Bell • Commerce Bancshares (NASDAQ:CBSH) is projected to report quarterly earnings at $1.03 per share on revenue of $383.31 million.

ACI

Posts navigation

Previous 1 2 3 … 12 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service